Results 161 to 170 of about 60,538 (223)
Incidents of sudden death during restraint of agitated individuals in Sweden between 1992 and 2024
Abstract Restraint‐related sudden deaths in agitated individuals raise complex questions at the intersection of medicine and law. Hyperactive delirium with extreme agitation as well as positional asphyxia due to restraint have been proposed to account for these deaths. However, the exact physiological mechanisms responsible and to what extent restraint
Alexander Tyr +4 more
wiley +1 more source
Stimulant use disorder indicative of increased serum soluble intercellular adhesion molecule-1 concentrations with altered brain reward and interoceptive processing. [PDF]
Burrows K +9 more
europepmc +1 more source
Medicines for Anxiety: A Hundred Years of Tranquillity and More to Come?
Human Psychopharmacology: Clinical and Experimental, Volume 41, Issue 2, March 2026.
David Nutt
wiley +1 more source
This study contributes to understanding the health impacts of co‐occurring alcohol use disorder (AUD) and metabolic dysfunction (MD). Using clinical data from the NIH, individuals with both AUD and MD (metAUD) had the strongest associations with greater hepatic injury and inflammation, a less favorable liver function test profile, higher fibrosis ...
Alexandra C. Wagner +9 more
wiley +1 more source
Computational Evaluation of the Use of Fluorescein Isothiocyanate as a Preliminary Test for Amphetamines and Cathinones. [PDF]
Rodrigues CHP, Bruni AT.
europepmc +1 more source
Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts +2 more
wiley +1 more source
Rare but relevant: MDMA and hyponatraemia
Abstract Conventionally used for its stimulant, empathogenic and entactogenic effects, 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) is one of the most commonly used psychoactive drugs, specifically among young adults and in nightlife and recreational party contexts.
Maria Rita Garcia +2 more
wiley +1 more source
Manufacturing Supply Chains and Imports in the ADHD Drug Shortage.
Currie J, Malinovskaya A.
europepmc +1 more source

